Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesExchange Rate EffectFree Cash FlowNet Cash FlowNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Beginning Cash Balance: 2019-2025

Historic Beginning Cash Balance for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $63.9 million.

  • Burning Rock Biotech's Beginning Cash Balance fell 27.09% to $63.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 55.95%. This contributed to the annual value of $84,284 for FY2024, which is 35.33% down from last year.
  • According to the latest figures from Q3 2025, Burning Rock Biotech's Beginning Cash Balance is $63.9 million, which was down 87.76% from $522.2 million recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Beginning Cash Balance registered a high of $1.2 billion during Q3 2022, and its lowest value of $63.9 million during Q3 2025.
  • For the 3-year period, Burning Rock Biotech's Beginning Cash Balance averaged around $344.9 million, with its median value being $134.7 million (2023).
  • As far as peak fluctuations go, Burning Rock Biotech's Beginning Cash Balance spiked by 1,987.38% in 2021, and later slumped by 90.53% in 2024.
  • Quarterly analysis of 5 years shows Burning Rock Biotech's Beginning Cash Balance stood at $258.9 million in 2021, then declined by 19.40% to $208.7 million in 2022, then slumped by 57.02% to $89.7 million in 2023, then decreased by 23.89% to $68.3 million in 2024, then decreased by 27.09% to $63.9 million in 2025.
  • Its last three reported values are $63.9 million in Q3 2025, $522.2 million for Q2 2025, and $522.2 million during Q1 2025.